Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 5/20 | 0.60 |
| ▸ | KCNH2 | Q12809 | 3/20 | 0.60 |
| ▸ | TP53 | P04637 | 3/20 | 0.58 |
| ▸ | THRB | P10828 | 2/20 | 0.47 |
| ▸ | HDAC1 | Q13547 | 3/20 | 0.46 |
| ▸ | HDAC6 | Q9UBN7 | 3/20 | 0.46 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.45 |
| ▸ | EGLN2 | Q96KS0 | 1/20 | 0.44 |
| ▸ | USP30 | Q70CQ3 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6984356 | 0.85 | SMN1; SMN2 (0.53) | TP53HDAC1HDAC6HDAC8SMN1; SMN2 | |
| SCHEMBL6979174 | 0.83 | TP53 (0.50) | IDO1KCNH2TP53HDAC1HDAC6 | |
| SCHEMBL6981022 | 0.83 | TP53 (0.51) | IDO1KCNH2TP53THRBHDAC1 | |
| SCHEMBL6977738 | 0.83 | TP53 (0.51) | IDO1KCNH2TP53HDAC1HDAC6 | |
| SCHEMBL6984804 | 0.82 | KCNH2 (0.45) | IDO1KCNH2TP53HDAC1HDAC6 | |
| SCHEMBL6979412 | 0.82 | NAMPT (0.49) | TP53HDAC1HDAC6HDAC8SMN1; SMN2 | |
| SCHEMBL7958782 | 0.82 | IDO1 (0.45) | IDO1KCNH2TP53THRBHDAC1 | |
| SCHEMBL7085009 | 0.82 | TP53 (0.49) | IDO1KCNH2TP53HDAC1HDAC6 | |
| SCHEMBL6985246 | 0.81 | TP53 (0.51) | IDO1KCNH2TP53THRBHDAC1 | |
| SCHEMBL7958965 | 0.81 | IDO1 (0.45) | IDO1KCNH2TP53THRBHDAC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6300342-B1 | FOR THERAPY OR INHIBITING THROMBUS FORMATION; FOR THERAPY OF FIBRIN-DEPENDENT INFLAMMATORY CONDITION | BOEHRINGER INGELHEIM PHARM KG (DE) | 2001-10-09 | — | — | US | disclosed |
| EP-0991624-A1 | PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT | Boehringer Ingelheim Pharma KG (DE) | 2000-04-12 | — | — | EP | disclosed |
| WO-1999000371-A1 | PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT | BOEHRINGER INGELHEIM PHARMA KG (DE) | 1999-01-07 | — | — | WO | disclosed |